Product Information
VENLAFAXINE HCL ER 150 MG TAB is a generic product labeled by Zydus Pharmaceuticals (USA) Inc., priced at $0.2367 per EA under NDC 70710135009. Its NADAC has been published 170 times since Mar 29, 2023.
Strength
150 mg/1
Manufacturer
Zydus Pharmaceuticals (USA) Inc.NDC
70710135009
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
VENLAFAXINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA215622On Market Since
9/1/2022
Pharmacological Classes
Price Statistics
The NADAC for VENLAFAXINE HCL ER 150 MG TAB has been published 170 times since Mar 29, 2023, and over the history we have for it it has risen 27.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2367 per EA |
|---|---|
| All-time high | $0.3859 (Aug 14, 2024) |
| All-time low | $0.1711 (May 22, 2024) |
| 52-week high | $0.3110 |
| 52-week low | $0.2085 |
| Median price | $0.2323 |
| Average price | $0.2423 |
| Largest weekly change | +83.6% (Jun 19, 2024) |
| Weeks tracked | 170 |
| Tracking since | Mar 29, 2023 |
Generic Alternatives
The matcher finds 6 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 6 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of VENLAFAXINE HCL ER 150 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for VENLAFAXINE HCL ER 150 MG TAB, manufactured by Zydus Pharmaceuticals (USA) Inc., is $0.2367 per EA (NDC 70710135009), effective Jun 24, 2026.
How has the price of VENLAFAXINE HCL ER 150 MG TAB changed over time?
Over the history we have for it, the NADAC for VENLAFAXINE HCL ER 150 MG TAB has risen 27.7%. It has been tracked across 170 weekly CMS publications since Mar 29, 2023.
What are the highest and lowest recorded NADAC prices for VENLAFAXINE HCL ER 150 MG TAB?
Since Mar 29, 2023, the NADAC for VENLAFAXINE HCL ER 150 MG TAB has ranged from a low of $0.1711 (May 22, 2024) to a high of $0.3859 (Aug 14, 2024), with a median of $0.2323 per EA.
Are there cheaper alternatives to VENLAFAXINE HCL ER 150 MG TAB?
6 NADAC-published products share the same active ingredient, strength, and dosage form as VENLAFAXINE HCL ER 150 MG TAB, but none are currently priced below it.
Who manufactures VENLAFAXINE HCL ER 150 MG TAB?
VENLAFAXINE HCL ER 150 MG TAB (NDC 70710135009) is labeled by Zydus Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification